Abstract |
Colorectal cancer (CRC) is a common cause of cancer and cancer-related death. Surgery is the only curative modality. Fluorescence-enhanced visualization of CRC with targeted fluorescent probes that can delineate boundaries and target tumor-specific biomarkers can increase rates of curative resection. Approaches to enhancing visualization of the tumor-to-normal tissue interface are active areas of investigation. Nonspecific dyes are the most-used approach, but tumor-specific targeting agents are progressing in clinical trials. The present narrative review describes the principles of fluorescence targeting of CRC for diagnosis and fluorescence-guided surgery with molecular biomarkers for preclinical or clinical evaluation.
|
Authors | Thinzar M Lwin, Michael A Turner, Siamak Amirfakhri, Hiroto Nishino, Robert M Hoffman, Michael Bouvet |
Journal | Cells
(Cells)
Vol. 11
Issue 2
(01 12 2022)
ISSN: 2073-4409 [Electronic] Switzerland |
PMID | 35053365
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review)
|
Chemical References |
- Biomarkers, Tumor
- Fluorescent Dyes
|
Topics |
- Animals
- Biomarkers, Tumor
(metabolism)
- Colonic Neoplasms
(surgery, therapy)
- Fluorescence
- Fluorescent Dyes
(chemistry)
- Humans
- Molecular Targeted Therapy
|